Cargando…
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive. There are many reasons why the development of a potent and durable HIV-1 vaccine is challenging, including the extraordinary genetic diversity of HIV-1 and its complex mechanisms of immune evasion. HIV-1 envel...
Autores principales: | Haynes, Barton F., Wiehe, Kevin, Borrow, Persephone, Saunders, Kevin O., Korber, Bette, Wagh, Kshitij, McMichael, Andrew J., Kelsoe, Garnett, Hahn, Beatrice H., Alt, Frederick, Shaw, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372928/ https://www.ncbi.nlm.nih.gov/pubmed/35962033 http://dx.doi.org/10.1038/s41577-022-00753-w |
Ejemplares similares
-
Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013) -
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021) -
HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014) -
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023) -
Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)